1593 related articles for article (PubMed ID: 15326067)
1. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
3. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
[TBL] [Abstract][Full Text] [Related]
4. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
5. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
6. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
[TBL] [Abstract][Full Text] [Related]
7. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
8. Hematocrit and the risk of coronary heart disease mortality.
Brown DW; Giles WH; Croft JB
Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA; Victor TW
Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
11. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
Stern MP; Williams K; Hunt KJ
Atheroscler Suppl; 2005 May; 6(2):3-6. PubMed ID: 15823490
[TBL] [Abstract][Full Text] [Related]
12. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
13. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?
Gao W;
Int J Obes (Lond); 2008 May; 32(5):757-62. PubMed ID: 18209738
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
[TBL] [Abstract][Full Text] [Related]
15. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Lorenzo C; Williams K; Hunt KJ; Haffner SM
Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
Lim HS; Lip GY; Beevers DG; Blann AD
Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
[TBL] [Abstract][Full Text] [Related]
19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
